These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8587600)

  • 21. The evolution of the psoriatic lesion.
    van de Kerkhof PC
    Br J Dermatol; 2007 Jul; 157(1):4-15. PubMed ID: 17578434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis.
    Balci DD; Duran N; Ozer B; Gunesacar R; Onlen Y; Yenin JZ
    Eur J Dermatol; 2009; 19(3):238-42. PubMed ID: 19286488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The quality of human skin xenografts on SCID mice: a noninvasive bioengineering approach.
    Kappes U; Schliemann-Willers S; Bankova L; Heinemann C; Fischer TW; Ziemer M; Schubert H; Norgauer J; Fluhr JW; Elsner P
    Br J Dermatol; 2004 Nov; 151(5):971-6. PubMed ID: 15541074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Staphylococcal epidermal necrolysis occasionally affects children].
    Persson G; Norrgren H; Hanson C; Moëll C; Ljungh A
    Lakartidningen; 1999 Mar; 96(12):1475-6. PubMed ID: 10222710
    [No Abstract]   [Full Text] [Related]  

  • 25. BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: a novel synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic skin-severe-combined immunodeficient mouse transplants after topical application.
    Bhagavathula N; Nerusu KC; Reddy M; Ellis CN; Chittiboyina A; Avery M; Pershadsingh HA; Kurtz TW; Varani J
    J Pharmacol Exp Ther; 2005 Dec; 315(3):996-1004. PubMed ID: 16109743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The psoriasis SCID mouse model: a tool for drug discovery?
    Boehncke WH
    Ernst Schering Res Found Workshop; 2005; (50):213-34. PubMed ID: 15526945
    [No Abstract]   [Full Text] [Related]  

  • 27. Animal models of psoriasis.
    Nickoloff BJ; Wrone-Smith T
    Nat Med; 1997 May; 3(5):475-6. PubMed ID: 9142104
    [No Abstract]   [Full Text] [Related]  

  • 28. N-eicosapentaenoyl-ethanolamine decreases the proliferation of psoriatic keratinocytes in a reconstructed psoriatic skin model.
    Simard M; Tremblay A; Morin S; Rioux G; Flamand N; Pouliot R
    Sci Rep; 2023 Jul; 13(1):12113. PubMed ID: 37495686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies.
    Brembilla NC; Boehncke WH
    Front Immunol; 2023; 14():1186455. PubMed ID: 37283755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanotransduction in Skin Inflammation.
    Shutova MS; Boehncke WH
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders.
    Schön MP
    Front Immunol; 2019; 10():1764. PubMed ID: 31402919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoreactive T-Lymphocytes in Inflammatory Skin Diseases.
    Boehncke WH; Brembilla NC
    Front Immunol; 2019; 10():1198. PubMed ID: 31191553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Effects of Synthetic Antimicrobial Peptides, TRAIL and NRP1 Blocking Peptides in Psoriatic Keratinocytes.
    Ryu S; Broussard L; Youn C; Song B; Norris D; Armstrong CA; Kim B; Song PI
    Chonnam Med J; 2019 May; 55(2):75-85. PubMed ID: 31161119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis.
    Schön MP; Erpenbeck L
    Front Immunol; 2018; 9():1323. PubMed ID: 29963046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.
    Soleymani T; Reddy SM; Cohen JM; Neimann AL
    Curr Rheumatol Rep; 2017 Nov; 20(1):1. PubMed ID: 29185062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on psoriasis immunopathogenesis and targeted immunotherapy.
    Mahil SK; Capon F; Barker JN
    Semin Immunopathol; 2016 Jan; 38(1):11-27. PubMed ID: 26573299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial ecology of the skin in the era of metagenomics and molecular microbiology.
    Hannigan GD; Grice EA
    Cold Spring Harb Perspect Med; 2013 Dec; 3(12):a015362. PubMed ID: 24296350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Putting together the psoriasis puzzle: an update on developing targeted therapies.
    Johnson-Huang LM; Lowes MA; Krueger JG
    Dis Model Mech; 2012 Jul; 5(4):423-33. PubMed ID: 22730473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism of the catechol-O-methyltransferase gene in Han Chinese patients with psoriasis vulgaris.
    Gao L; Li H; Li K; Shen Z; Liu L; Li C; Zhang Z; Liu Y
    Genet Mol Biol; 2009 Jan; 32(1):32-6. PubMed ID: 21637643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a bioengineered skin-humanized mouse model for psoriasis: dissecting epidermal-lymphocyte interacting pathways.
    Guerrero-Aspizua S; García M; Murillas R; Retamosa L; Illera N; Duarte B; Holguín A; Puig S; Hernández MI; Meana A; Jorcano JL; Larcher F; Carretero M; Del Río M
    Am J Pathol; 2010 Dec; 177(6):3112-24. PubMed ID: 20971736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.